Edith Perez, MD: Anti-HER2 Therapies
Dr. Edith Perez sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss her recent research with Anti-HER2 therapies presented at SABCS 2012.
Edith A. Perez, MD is Deputy Director, Mayo Clinic Cancer Center — Group Vice Chair, Alliance for Clinical Trials in Oncology — Serene M. and Frances C. Durling Professor of Medicine, Division of Hematology/Oncology, University of Miami, Mayo Medical School, Jacksonville, Florida
Advocacy and educational support provided in part by: